Interventions for valvular disease Outcomes and predictors of success and complications for paravalvular leak closure: an analysis of the SpanisH real-wOrld paravalvular LEaks closure (HOLE) registry Garcia E, Arzamendi D, Jimenez-Quevedo P, Sarnago F, Martí G, Sánchez-Recalde A, Lasa-Larraya G, Sancho M, Iñiguez A, Goicolea J, Roman K, Alonso-Briales J, Molina E, Calabuig J, Freixa X, Berenguer A, Valdés Chávarri M, Vázquez N, Diaz J, Cruz-Gonzalez I March 20, 2017 | 10.4244/EIJ-D-16-00581
Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial Chevalier B, Wijns W, Silber S, Garcia E, Serra A, Paunovic D, Serruys P September 22, 2015 | 10.4244/EIJY14M12_13
Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies Grundeken M.J, Asgedom S, Damman P, Lesiak M, Norell M, Garcia E, Bethencourt A, Woudstra P, Koch K, Vis M, Henriques J, Onuma Y, Foley DP, Bartorelli A, Stella P, Thijssen J, de Winter R, Wykrzykowska J June 28, 2013 | 10.4244/EIJV9I2A34
Safety of lone thrombus aspiration without concomitant coronary stenting in selected patients with acute myocardial infarction Escaned J, Echavarría-Pinto M, Gorgadze T, Gonzalo N, Armengol F, Hernandez R, Jimenez-Quevedo P, Nunez-Gil I, Perez-Vizcayno M, Alfonso F, Banuelos C, Ibañez B, Garcia E, Fernandez Ortiz A, Macaya C February 22, 2013 | 10.4244/EIJV8I10A178
Paravalvular leaks: mechanisms, diagnosis and management Garcia E, Sandoval J, Unzue L, Hernández-Antolín R, Almería C, Macaya C September 30, 2012 | 10.4244/EIJV8SQA9
A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry Agostoni P, Foley DP, Lesiak M, Belkacemi A, Dens J, Kumsars I, Scott B, Oemrawsingh P, Dubois C, Garcia E, Lefèvre T, Stella P March 21, 2012 | 10.4244/EIJV7I11A204
A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated By EveroLimus-Eluting Stent) trial Moreno R, Garcia E, Teles R, Almeida M, Carvalho H, Sabaté M, Martin-Reyes R, Rumoroso J-R, Galeote G, Goicolea F, Moreu J, Mainar V, Mauri J, Ferreira R, Valdes M, de Prado A, Martin-Yuste V, Jimenez-Valero S, Sánchez-Recalde A, Calvo L, de Sa E, Macaya C, López-Sendón J-L May 25, 2010
A novel ultra-thin bare metal stent (BMS): results from a worldwide registry Blanchard D, Danzi G, Urban P, Moseri M, Juergens C, Guyon P, Nowak B, Tresukosol D, Suttorp MJ, Farshid A, Kornowski R, Garcia E, Yeend R, Nagai H, Paunovic D August 20, 2007
Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial Chevalier B, Serruys P, Silber S, Garcia E, Suryapranata H, Hauptmann K-E, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D February 20, 2007
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019